An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance

Thijs J. Hagenbeek(Kaiser Permanente San Francisco Medical Center), Anwesha Dey(Unknown)
Nature Cancer
June 5, 2023
Cited by 188


Related Papers